Christopher DeZorzi

Christopher DeZorzi

Auto-generated profile, based on publicly available information

Christopher DeZorzi

Saint Luke's Mid America Heart Institute and the University of Kanas City-Missouri, Kansas City, MO

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Cardiac Failure
Verified
Journal Article
Closed access
YSYasser Sammour
Yasser Sammour
CDChristopher Dezorzi
Christopher Dezorzi
BABethany A. Austin
Bethany A. Austin
ABA. Michael Borkon
A. Michael Borkon
MEMark P. Everley
Mark P. Everley
BSBrett W. Sperry
Brett W. Sperry

16 October 2018 in Cardiology Research and Practice
Verified
Journal Article
Open access
PDF file
CDChristopher DeZorzi
Christopher DeZorzi
As advances in medical technology arise and the availability of cancer treatment increases, an increased number of patients are receiving cancer treatment. Radiation therapy has evolved to become one of the cornerstones of treatment for various types of cancers. One of the long-term consequences of radiation therapy is radiation-induced coronary artery disease (RICAD). Although the pathophysiology of RICAD may be slightly different and more acute onset than the commonly seen “generic” coronary artery disease, it is common practice to treat RICAD in the same method as nonradiation-induced CAD. This paper summarizes the current research available on the topic and shows there is not enough research to obtain significant data about outcomes and restenosis rates of PCI or outcomes of CABG in RICAD. The aim of this review is to create a concise and easy-to-follow review of the relevant data regarding RICAD and hopefully spark further interest in future studies in this field.

12 September 2019 in Cardiology Research and Practice
Verified
Journal Article
Open access
PDF file
TRTyler P. Rasmussen
Tyler P. Rasmussen
NWNoah N. Williford
Noah N. Williford
CDChristopher DeZorzi
Christopher DeZorzi
AHAziz Hammoud
Aziz Hammoud
BBBrenden J. Boyle
Brenden J. Boyle
MGMilena Anna Gebska
Milena Anna Gebska
The cumulative incidence of systolic heart failure is similar in men and women. However, major prognostic differences exist between genders. We sought to measure gender differences in furosemide prescribing patterns for patients with preexisting heart failure with reduced ejection fraction (HFrEF) admitted with Stage C acute decompensation, regardless of the underlying cause. We conducted a single-center retrospective analysis of patients admitted between 2015 and 2018 for acute on chronic decompensated HFrEF. Primary outcomes were differences in initial furosemide dose, total dose over the first 24 hours of hospitalization, and total dose during the entire hospitalization between women and men. Secondary outcomes included acute kidney injury (AKI), intubation, noninvasive ventilation (NIV), and in-hospital 30-day and 1-year mortality. We studied 434 patients (31% female) with similar baseline characteristics. Females received significantly less furosemide compared to men for the initial dose, over the first 24 hours, and throughout their hospitalization. However, AKI was more prevalent in women versus men (p=0.008). Females admitted for acute on chronic decompensated HFrEF receive significantly less furosemide when compared to men, but developed more AKI prior to discharge.

28 May 2021 in Echocardiography
Verified
Journal Article
Closed access
PDF file
CDChristopher DeZorzi
Christopher DeZorzi
AMAlan Marsh
Alan Marsh
TBTracy Binkley
Tracy Binkley
AFAdam Fleddermann
Adam Fleddermann
TGTravis Gratton
Travis Gratton
AMAnthony Magalski
Anthony Magalski

6 June 2018 in Case Reports in Cardiology
Verified
Journal Article
Open access
PDF file
CDChristopher DeZorzi
Christopher DeZorzi
KHKatherine I. Harris
Katherine I. Harris
This case presentation discusses an extremely rare diagnosis presenting with common symptoms, attributed to influenza, which were not investigated further when clear cardiac symptoms developed. The patient initially presented with symptoms consistent with influenza, but when orthopnea and dyspnea on exertion developed, these cardiac symptoms continued to be attributed to a postviral syndrome and were not further evaluated. Premature closure bias contributed to a delay in diagnosing a rare cardiac condition. The diagnostic momentum, or the continuing of a diagnostic label, occurred across multiple providers and settings. This case demonstrates the risk of premature closure and diagnostic momentum and reminds clinicians to reframe the differential diagnosis as more information on history or physical exam becomes available.

14 May 2018 in Journal of Medical Case Reports
Verified
Journal Article
Open access
CDChristopher DeZorzi
Christopher DeZorzi
RFRuth Fernandez-Ruiz
Ruth Fernandez-Ruiz
SGSarika Gupta
Sarika Gupta
KHKatherine Harris
Katherine Harris
This case describes an unusual presentation of an intracranial hemorrhage first thought to be metastatic disease on computed tomography and magnetic resonance imaging. The healthcare team completed an exhaustive search for a primary malignancy that was negative. Final diagnosis on brain biopsy showed intercranial hemorrhage secondary to cerebral amyloid angiopathy. With an increasing number of elderly patients and the rising cost of health care, this case can serve as a reminder to clinicians about their own responsibilities in limiting the cost of health care. This is a case report about a 72-year-old white woman with an intracranial hemorrhage secondary to cerebral amyloid angiopathy. The brain lesions on computed tomography/magnetic resonance imaging mimicked a metastatic process until a brain biopsy could give a definitive diagnosis that was completely unexpected. Cerebral amyloid angiopathy is a rare cause of intracerebral hemorrhage and this diagnosis is important to consider in older patients on anticoagulation. Cerebral amyloid angiopathy is a rare diagnosis but should be considered in elderly patients on anticoagulation presenting with imaging findings consistent with intracerebral hemorrhage. While metastatic disease is a more common cause of intracerebral hemorrhage, cerebral amyloid angiopathy should remain in the differential diagnosis. This case report serves as a teaching point to clinicians in cases involving an older patient on anticoagulation.